To the Editor,
The recent letter by Aytaç and colleagues, entitled "Poland syndrome associated with pernicious anemia and gastric dysplasia", gives me an opportunity to question the vitamin B12 dose administered for the treatment of pernicious anemia [1] .
Vitamin B12 was initiated by the authors (1000 µg daily for 5 days, 1000 µg weekly for 4 weeks, and then 1000 µg monthly for life) without taking into account that its daily requirement is 2 µg and its half-life is more than 350 days [2, 3, 4, 5] .
Although to my knowledge, vitamin B12 toxicity has not been reported, its extra benefit related to huge doses is also not known.
On this occasion, I would like to bring to attention that the Poland syndrome's association with leukemia was previously reported by us [6] .
